Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

159 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate.
Roskell NS, Lip GY, Noack H, Clemens A, Plumb JM. Roskell NS, et al. Among authors: noack h. Thromb Haemost. 2010 Dec;104(6):1106-15. doi: 10.1160/TH10-10-0642. Epub 2010 Oct 21. Thromb Haemost. 2010. PMID: 20967400
Assessing the impact of dabigatran and warfarin on health-related quality of life: results from an RE-LY sub-study.
Monz BU, Connolly SJ, Korhonen M, Noack H, Pooley J. Monz BU, et al. Among authors: noack h. Int J Cardiol. 2013 Oct 3;168(3):2540-7. doi: 10.1016/j.ijcard.2013.03.059. Epub 2013 May 8. Int J Cardiol. 2013. PMID: 23664436 Clinical Trial.
Dabigatran is effective with a favourable safety profile in normal and overweight patients undergoing major orthopaedic surgery: a pooled analysis.
Eriksson BI, Dahl OE, Feuring M, Clemens A, Noack H, Hantel S, Friedman RJ, Huo M. Eriksson BI, et al. Among authors: noack h. Thromb Res. 2012 Nov;130(5):818-20. doi: 10.1016/j.thromres.2012.07.004. Epub 2012 Jul 26. Thromb Res. 2012. PMID: 22840686
Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events.
Majeed A, Hwang HG, Eikelboom JW, Connolly S, Wallentin L, Feuring M, Brueckmann M, Noack H, Yusuf S, Schulman S. Majeed A, et al. Among authors: noack h. Thromb Res. 2016 Apr;140:81-88. doi: 10.1016/j.thromres.2016.02.005. Epub 2016 Feb 22. Thromb Res. 2016. PMID: 26908016 Clinical Trial.
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.
Douketis JD, Healey JS, Brueckmann M, Eikelboom JW, Ezekowitz MD, Fraessdorf M, Noack H, Oldgren J, Reilly P, Spyropoulos AC, Wallentin L, Connolly SJ. Douketis JD, et al. Among authors: noack h. Thromb Haemost. 2015 Mar;113(3):625-32. doi: 10.1160/TH14-04-0305. Epub 2014 Dec 4. Thromb Haemost. 2015. PMID: 25472710
Patient outcomes using the European label for dabigatran. A post-hoc analysis from the RE-LY database.
Lip GY, Clemens A, Noack H, Ferreira J, Connolly SJ, Yusuf S. Lip GY, et al. Among authors: noack h. Thromb Haemost. 2014 May 5;111(5):933-42. doi: 10.1160/TH13-09-0734. Epub 2013 Dec 11. Thromb Haemost. 2014. PMID: 24326736
Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials.
Rosencher N, Noack H, Feuring M, Clemens A, Friedman RJ, Eriksson BI. Rosencher N, et al. Among authors: noack h. Thromb J. 2012 Jun 18;10(1):9. doi: 10.1186/1477-9560-10-9. Thromb J. 2012. PMID: 22709460 Free PMC article.
Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: no increased risk of bleeding.
Friedman RJ, Kurth A, Clemens A, Noack H, Eriksson BI, Caprini JA. Friedman RJ, et al. Among authors: noack h. Thromb Haemost. 2012 Jul;108(1):183-90. doi: 10.1160/TH11-08-0589. Epub 2012 May 3. Thromb Haemost. 2012. PMID: 22552763 Clinical Trial.
A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN).
Van de Werf F, Brueckmann M, Connolly SJ, Friedman J, Granger CB, Härtter S, Harper R, Kappetein AP, Lehr T, Mack MJ, Noack H, Eikelboom JW. Van de Werf F, et al. Among authors: noack h. Am Heart J. 2012 Jun;163(6):931-937.e1. doi: 10.1016/j.ahj.2012.03.011. Am Heart J. 2012. PMID: 22709744 Clinical Trial.
Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies.
Roskell NS, Samuel M, Noack H, Monz BU. Roskell NS, et al. Among authors: noack h. Europace. 2013 Jun;15(6):787-97. doi: 10.1093/europace/eut001. Epub 2013 Feb 13. Europace. 2013. PMID: 23407628 Free PMC article. Review.
159 results
Jump to page
Feedback